(Reuters) -AbbVie Inc said on Tuesday the U.S. health regulator approved its once-daily oral medicine for preventive treatment of migraine in adults, .
(Reuters) -AbbVie Inc said on Tuesday the U.S. health regulator approved its once-daily oral medicine for preventive treatment of migraine in adults, .
Following the Recent Label Expansion, Biohaven s Nurtec ODT Has Come Out Strong in the Migraine Prevention Market, According to Spherix Global Insights prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
University of Tennessee researchers found that the peptides behind migraine pain can trigger insulin production in mice, and the study could lead to better methods for preventing or treating diabetes.
Here s Why Biohaven Pharmaceutical Is Soaring Today fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.